Arellano, Lea F.
HRN: 01-44-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/16/2023
CEFUROXIME 1.5GM (VIAL)
02/16/2023
02/23/2023
IVTT
1.5g
Q8h
Fracture, Closed, Complete, Displaced, Radius-Ulna, Left Sec To MVA
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes